{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T11:11:36Z","timestamp":1774782696780,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":45,"publisher":"Springer US","isbn-type":[{"value":"9781071647417","type":"print"},{"value":"9781071647424","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/978-1-0716-4742-4_15","type":"book-chapter","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T16:28:38Z","timestamp":1756398518000},"page":"323-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Generating mRNA Encoding Anti-HBV Designer Epigenome Modifiers"],"prefix":"10.1007","author":[{"given":"Prashika","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tafadzwa","family":"Mlambo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristie","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Mussolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Arbuthnot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah","family":"Ely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"issue":"3","key":"15_CR1","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jhep.2009.05.022","volume":"51","author":"M Levrero","year":"2009","unstructured":"Levrero M et al (2009) Control of cccDNA function in hepatitis B virus infection. J Hepatol 51(3):581\u2013592","journal-title":"J Hepatol"},{"key":"15_CR2","doi-asserted-by":"publisher","first-page":"1169770","DOI":"10.3389\/fmicb.2023.1169770","volume":"14","author":"H Guo","year":"2023","unstructured":"Guo H, Urban S, Wang W (2023) In vitro cell culture models to study hepatitis B and D virus infection. Front Microbiol 14:1169770","journal-title":"Front Microbiol"},{"key":"15_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.08.012","volume":"124","author":"SKK Mani","year":"2019","unstructured":"Mani SKK, Andrisani O (2019) Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma. Cytokine 124:154518","journal-title":"Cytokine"},{"issue":"3","key":"15_CR4","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/hep.21299","volume":"44","author":"A Laras","year":"2006","unstructured":"Laras A et al (2006) Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 44(3):694\u2013702","journal-title":"Hepatology"},{"key":"15_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02048","volume":"10","author":"Y Chen","year":"2019","unstructured":"Chen Y, Tian Z (2019) HBV-induced immune imbalance in the development of HCC. Front Immunol 10:478201","journal-title":"Front Immunol"},{"key":"15_CR6","unstructured":"WHO (2022) World Health Organisation. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b"},{"issue":"20","key":"15_CR7","doi-asserted-by":"publisher","first-page":"01032","DOI":"10.1128\/jvi.01032-19","volume":"93","author":"J Hu","year":"2019","unstructured":"Hu J, Protzer U, Siddiqui A (2019) Revisiting hepatitis B virus: challenges of curative therapies. J Virol 93(20):01032\u201301019. https:\/\/doi.org\/10.1128\/jvi.01032-19","journal-title":"J Virol"},{"issue":"9","key":"15_CR8","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","volume":"7","author":"BS Sheena","year":"2022","unstructured":"Sheena BS et al (2022) Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Gastroenterol Hepatol 7(9):796\u2013829","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"15_CR9","doi-asserted-by":"publisher","first-page":"213","DOI":"10.3390\/ijms22010213","volume":"22","author":"HW Lee","year":"2020","unstructured":"Lee HW, Lee JS, Ahn SH (2020) Hepatitis B virus cure: targets and future therapies. Int J Mol Sci 22(1):213","journal-title":"Int J Mol Sci"},{"issue":"10","key":"15_CR10","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/mt.2013.170","volume":"21","author":"K Bloom","year":"2013","unstructured":"Bloom K et al (2013) Inactivation of hepatitis B virus replication in cultured cells and in vivo with engineered transcription activator-like effector nucleases. Mol Ther 21(10):1889\u20131897","journal-title":"Mol Ther"},{"issue":"5","key":"15_CR11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097579","volume":"9","author":"ND Weber","year":"2014","unstructured":"Weber ND et al (2014) AAV-mediated delivery of zinc finger nucleases targeting hepatitis B virus inhibits active replication. PLoS One 9(5):e97579","journal-title":"PLoS One"},{"key":"15_CR12","doi-asserted-by":"publisher","first-page":"e186","DOI":"10.1038\/mtna.2014.38","volume":"3","author":"S-R Lin","year":"2014","unstructured":"Lin S-R et al (2014) The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates in vivo. Mol Ther Nucleic Acids 3:e186","journal-title":"Mol Ther Nucleic Acids"},{"issue":"2","key":"15_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.canlet.2006.11.010","volume":"252","author":"MA Feitelson","year":"2007","unstructured":"Feitelson MA, Lee J (2007) Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett 252(2):157\u2013170","journal-title":"Cancer Lett"},{"issue":"1","key":"15_CR14","doi-asserted-by":"publisher","first-page":"219\u2013232. e214","DOI":"10.1016\/j.cell.2016.09.006","volume":"167","author":"A Amabile","year":"2016","unstructured":"Amabile A et al (2016) Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167(1):219\u2013232. e214","journal-title":"Cell"},{"issue":"8","key":"15_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki M, Tomberg K, Bradley A (2018) Repair of double-strand breaks induced by CRISPR\u2013Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol 36(8):765\u2013771","journal-title":"Nat Biotechnol"},{"issue":"9","key":"15_CR16","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1093\/nar\/gky171","volume":"46","author":"T Mlambo","year":"2018","unstructured":"Mlambo T et al (2018) Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells. Nucleic Acids Res 46(9):4456\u20134468","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"15_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1177\/1087057112463066","volume":"18","author":"X Zhao","year":"2013","unstructured":"Zhao X et al (2013) Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx gene integrated into a human hepatocellular carcinoma cell line. J Biomol Screen 18(4):378\u2013387","journal-title":"J Biomol Screen"},{"issue":"4","key":"15_CR18","first-page":"2169","volume":"41","author":"W Luo","year":"2018","unstructured":"Luo W et al (2018) Engineered zinc-finger transcription factors inhibit the replication and transcription of HBV in vitro and in vivo. Int J Mol Med 41(4):2169\u20132176","journal-title":"Int J Mol Med"},{"key":"15_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1134\/S0006297914020047","volume":"79","author":"L Xirong","year":"2014","unstructured":"Xirong L et al (2014) Hepatitis B virus can be inhibited by DNA methyltransferase 3a via specific zinc-finger-induced methylation of the X promoter. Biochem Mosc 79:111\u2013123","journal-title":"Biochem Mosc"},{"key":"15_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4436-y","volume":"19","author":"K Bloom","year":"2019","unstructured":"Bloom K et al (2019) Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA. BMC Infect Dis 19:1\u201310","journal-title":"BMC Infect Dis"},{"issue":"2","key":"15_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2893.2007.00905.x","volume":"15","author":"P Vivekanandan","year":"2008","unstructured":"Vivekanandan P, Thomas D, Torbenson M (2008) Hepatitis B viral DNA is methylated in liver tissues. J Viral Hepat 15(2):103\u2013107","journal-title":"J Viral Hepat"},{"issue":"1","key":"15_CR22","doi-asserted-by":"publisher","first-page":"10478","DOI":"10.1038\/srep10478","volume":"5","author":"S Jain","year":"2015","unstructured":"Jain S et al (2015) Comprehensive DNA methylation analysis of hepatitis B virus genome in infected liver tissues. Sci Rep 5(1):10478","journal-title":"Sci Rep"},{"issue":"10","key":"15_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0110442","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y et al (2014) Transcription of hepatitis B virus covalently closed circular DNA is regulated by CpG methylation during chronic infection. PLoS One 9(10):e110442","journal-title":"PLoS One"},{"issue":"23","key":"15_CR24","doi-asserted-by":"publisher","first-page":"3182","DOI":"10.3748\/wjg.v27.i23.3182","volume":"27","author":"P Singh","year":"2021","unstructured":"Singh P, Kairuz D, Arbuthnot P, Bloom K (2021) Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach. World J Gastroenterol 27(23):3182","journal-title":"World J Gastroenterol"},{"issue":"5","key":"15_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/655398","volume":"202","author":"P Kaur","year":"2010","unstructured":"Kaur P et al (2010) DNA methylation of hepatitis B virus (HBV) genome associated with the development of hepatocellular carcinoma and occult HBV infection. J Infect Dis 202(5):700\u2013704","journal-title":"J Infect Dis"},{"issue":"2","key":"15_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0056711","volume":"8","author":"Y Zhang","year":"2013","unstructured":"Zhang Y et al (2013) Comparative analysis of CpG islands among HBV genotypes. PLoS One 8(2):e56711","journal-title":"PLoS One"},{"issue":"2","key":"15_CR27","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/cancers14020448","volume":"14","author":"C Wu","year":"2022","unstructured":"Wu C et al (2022) Identification of tumor antigens and immune subtypes for the development of mRNA vaccines and individualized immunotherapy in soft tissue sarcoma. Cancers 14(2):448","journal-title":"Cancers"},{"key":"15_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.nantod.2018.10.005","volume":"23","author":"Z Zhong","year":"2018","unstructured":"Zhong Z et al (2018) mRNA therapeutics deliver a hopeful message. Nano Today 23:16\u201339","journal-title":"Nano Today"},{"issue":"11","key":"15_CR29","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3 K et al (2008) Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol Ther 16(11):1833\u20131840","journal-title":"Mol Ther"},{"issue":"21","key":"15_CR30","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1093\/nar\/gkr695","volume":"39","author":"K Karik\u00f3","year":"2011","unstructured":"Karik\u00f3 K, Muramatsu H, Ludwig J, Weissman D (2011) Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA. Nucleic Acids Res 39(21):e142\u2013e142","journal-title":"Nucleic Acids Res"},{"issue":"17","key":"15_CR31","doi-asserted-by":"publisher","first-page":"R764","DOI":"10.1016\/j.cub.2010.06.037","volume":"20","author":"S Payankaulam","year":"2010","unstructured":"Payankaulam S, Li LM, Arnosti DN (2010) Transcriptional repression: conserved and evolved features. Curr Biol 20(17):R764\u2013R771","journal-title":"Curr Biol"},{"issue":"5294","key":"15_CR32","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1126\/science.274.5294.1931","volume":"274","author":"M Lewis","year":"1996","unstructured":"Lewis M (1996) Response: DNA looping and Lac repressor\u2014CAP interaction. Science 274(5294):1931\u20131932","journal-title":"Science"},{"key":"15_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.omtn.2019.02.018","volume":"15","author":"M Baiersd\u00f6rfer","year":"2019","unstructured":"Baiersd\u00f6rfer M et al (2019) A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA. Mol Ther Nucleic Acids 15:26\u201335","journal-title":"Mol Ther Nucleic Acids"},{"key":"15_CR34","doi-asserted-by":"publisher","first-page":"6781","DOI":"10.12659\/MSM.910049","volume":"24","author":"L Chen","year":"2018","unstructured":"Chen L et al (2018) Differences in Cpg island distribution between subgenotypes of the hepatitis B virus genotype. Med Sci Monit 24:6781","journal-title":"Med Sci Monit"},{"key":"15_CR35","first-page":"51","volume-title":"Methods in enzymology","author":"JF Milligan","year":"1989","unstructured":"Milligan JF, Uhlenbeck OC (1989) [5] Synthesis of small RNAs using T7 RNA polymerase. In: Methods in enzymology, vol 180. Elsevier, pp 51\u201362"},{"issue":"18","key":"15_CR36","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.1093\/nar\/12.18.7035","volume":"12","author":"D Melton","year":"1984","unstructured":"Melton D et al (1984) Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 12(18):7035\u20137056","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"15_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/0042-6822(72)90119-5","volume":"48","author":"JJ Dunn","year":"1972","unstructured":"Dunn JJ, McAllister WT, Bautz EK (1972) In vitro transcription of T3 DNA by Escherichia coli and T3 polymerases. Virology 48(1):112\u2013125","journal-title":"Virology"},{"key":"15_CR38","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.addr.2020.05.010","volume":"168","author":"A Ely","year":"2021","unstructured":"Ely A, Singh P, Smith TS, Arbuthnot P (2021) In vitro transcribed mRNA for expression of designer nucleases: Advantages as a novel therapeutic for the management of chronic HBV infection. Adv Drug Deliv Rev 168:134\u2013146","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"15_CR39","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1261\/rna.1007408","volume":"14","author":"SR Nallagatla","year":"2008","unstructured":"Nallagatla SR, Bevilacqua PC (2008) Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner. RNA 14(6):1201\u20131213","journal-title":"RNA"},{"issue":"21","key":"15_CR40","doi-asserted-by":"publisher","first-page":"8783","DOI":"10.1093\/nar\/15.21.8783","volume":"15","author":"JF Milligan","year":"1987","unstructured":"Milligan JF, Groebe DR, Witherell GW, Uhlenbeck OC (1987) Oligoribonucleotide synthesis using T7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res 15(21):8783\u20138798","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"15_CR41","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ymeth.2013.08.034","volume":"65","author":"FT Edelmann","year":"2014","unstructured":"Edelmann FT, Niedner A, Niessing D (2014) Production of pure and functional RNA for in vitro reconstitution experiments. Methods 65(3):333\u2013341","journal-title":"Methods"},{"issue":"2","key":"15_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.39","volume":"1","author":"JM Henderson","year":"2021","unstructured":"Henderson JM et al (2021) Cap 1 messenger RNA synthesis with co-transcriptional cleancap\u00ae analog by in vitro transcription. Curr Protoc 1(2):e39","journal-title":"Curr Protoc"},{"issue":"13","key":"15_CR43","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1080\/15384101.2018.1486164","volume":"17","author":"I Kocmik","year":"2018","unstructured":"Kocmik I et al (2018) Modified ARCA analogs providing enhanced translational properties of capped mRNAs. Cell Cycle 17(13):1624\u20131636","journal-title":"Cell Cycle"},{"issue":"3","key":"15_CR44","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193804","volume":"13","author":"F Picard-Jean","year":"2018","unstructured":"Picard-Jean F et al (2018) 2\u2019-O-methylation of the mRNA cap protects RNAs from decapping and degradation by DXO. PLoS One 13(3):e0193804","journal-title":"PLoS One"},{"issue":"2","key":"15_CR45","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3390\/pharmaceutics14020328","volume":"14","author":"I Vlatkovic","year":"2022","unstructured":"Vlatkovic I et al (2022) Ribozyme assays to quantify the capping efficiency of in vitro-transcribed mRNA. Pharmaceutics 14(2):328","journal-title":"Pharmaceutics"}],"container-title":["Methods in Molecular Biology","RNA Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4742-4_15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T07:02:07Z","timestamp":1774767727000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4742-4_15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9781071647417","9781071647424"],"references-count":45,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4742-4_15","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"29 August 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}